MEDP
Medpace Holdings, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-10
Figures on this page computed 2026-11-08 12:32 UTC
Last close
656.77USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-10
41.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-10
450.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-10
- 10-K for 2025, filed 2026-02-10
- 10-K for 2025, filed 2026-02-10
- 10-Q for 2025, filed 2026-10-22
- 10-K for 2025, filed 2026-02-10
- 10-Q for 2025, filed 2026-10-22
17.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-10
- 10-K for 2025, filed 2026-02-10
26.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-10
- 10-K for 2025, filed 2026-02-10
0.30Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
- 10-K for 2025, filed 2026-02-10
- 10-Q for 2025, filed 2026-10-22
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.12 against 0.36 on the market's range.
- Growth22.3%74 of 100, above its sector
- Returns on capital450.0%99 of 100, above its sector
- Margins21.1%87 of 100, above its sector
- Price41.8x12 of 100, below its sector
- Safety0.3056 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 1 of 5- Profit on each unit of sales17.8%9.0%Ahead
Higher is better here.
- Return on the capital it uses450%9.0%Ahead
Higher is better here.
- Sales growth over five years22.3%3.2%Ahead
Higher is better here.
- Debt against equity0.300.89Ahead
Lower is better here.
- Gross marginn/a33.2%n/a
Higher is better here.
- Price against earnings41.8x28.8xBehind
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Quest Diagnostics Incorporated, MEDP is behind on 1 of 5 measures.
Against Quest Diagnostics Incorporated, MEDP is behind on 1 of 5 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-10
Profit on each unit of sales17.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
Return on the capital it uses450.0%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
Sales growth over five years22.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
Debt against equity0.30
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
Gross marginn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD
Price against earnings41.8x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001668397-26-000006
- Reported in
- USD